Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Exscientia Plc - American Depositary Shares (NQ: EXAI ) 4.840 UNCHANGED Last Price Updated: 4:00 PM EST, Nov 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 4.840 Bid (Size) 4.700 (1) Ask (Size) 4.850 (1) Prev. Close 4.840 Today's Range 4.840 - 4.840 52wk Range 3.800 - 7.910 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News NVIDIA Invested in These 2 AI Stocks, Should You? December 02, 2024 Discover 2 compelling AI stocks NVIDIA (NASDAQ: NVDA) has invested in. Learn how the AI leader's vision can guide your portfolio in the tech revolution. Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence Product Safety Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery November 20, 2024 From Recursion Pharmaceuticals, Inc. Via GlobeNewswire Performance YTD -22.62% -22.62% 1 Month N/A N/A 3 Month -5.84% -5.84% 6 Month -8.68% -8.68% 1 Year -26.67% -26.67% More News Read More Exscientia Achieves Milestones for Two Programmes in Sanofi Collaboration October 16, 2024 From Exscientia plc Via Business Wire Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024 October 09, 2024 From Exscientia plc Via Business Wire 12 Health Care Stocks Moving In Tuesday's After-Market Session October 08, 2024 Via Benzinga AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week September 15, 2024 Via Talk Markets AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th September 10, 2024 Via Talk Markets Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone! September 05, 2024 Via Talk Markets Topics Economy Exposures Economy Exscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference August 28, 2024 From Exscientia plc Via Business Wire Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week August 27, 2024 Via Talk Markets The Bull Thesis for Recursion Pharmaceuticals Stock Just Got Stronger. Here's Why. August 18, 2024 Via The Motley Fool EXAI Stock Earnings: Exscientia Misses EPS, Misses Revenue for Q2 2024 August 15, 2024 Via InvestorPlace Exscientia Business Update for Second Quarter and First Half 2024 August 15, 2024 From Exscientia plc Via Business Wire AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD August 14, 2024 Via Talk Markets How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates August 14, 2024 Via FinancialNewsMedia Topics Artificial Intelligence Exposures Artificial Intelligence Is Recursion Pharmaceuticals a Buy Ahead of Its Merger With Exscientia? August 11, 2024 Via The Motley Fool Topics Artificial Intelligence Exposures Artificial Intelligence How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates August 14, 2024 From FN Media Group LLC Via GlobeNewswire AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals August 08, 2024 Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities August 08, 2024 From Recursion Pharmaceuticals, Inc. Via GlobeNewswire AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD July 30, 2024 Via Talk Markets AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD July 18, 2024 Via Talk Markets Exscientia Acquires Full Rights to Potential Best-in-Class CDK7 Inhibitor Ahead of Phase 1 Dose Escalation Data Readout July 18, 2024 From Exscientia plc Via Business Wire Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD July 14, 2024 Via Talk Markets Exscientia Launches AWS AI-powered Platform to Advance Drug Discovery July 10, 2024 From Exscientia plc Via Business Wire 3 Small-Cap Stocks With Explosive 2X Growth Potential July 08, 2024 Via InvestorPlace Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
